Literature DB >> 18448802

The other side of the Maillard reaction.

Ram H Nagaraj1, Ashis Biswas, Antonia Miller, Tomoko Oya-Ito, Manjunatha Bhat.   

Abstract

The Maillard reaction plays an important role in eye lens aging and cataract formation. Methylglyoxal (MGO) is a metabolic dicarbonyl compound present in the lens. It reacts with arginine residues in lens proteins to form advanced glycation end products (AGEs), such as hydroimidazolones and argpyrimidine. alpha-Crystallin, comprising alphaA- and alphaB-crystallin, is a major protein of the lens and it functions as a chaperone protein. We have found that upon reaction with MGO, human alphaA-crystallin becomes a more effective chaperone. Modification of specific arginine residues to AGEs appears to be the reason. Mutation of these arginine residues to alanine mirrors the effect of MGO, suggesting neutralization of the positive charge on arginine residues as a cause for improved chaperone function. Reaction with MGO also blocks the loss of the chaperone function of alphaA-crystallin caused by nonenzymatic glycation by ascorbate and ribose. These findings suggest that low levels of MGO might help the lens remain transparent during aging.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18448802     DOI: 10.1196/annals.1433.045

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  3 in total

1.  The combined effect of acetylation and glycation on the chaperone and anti-apoptotic functions of human α-crystallin.

Authors:  Rooban B Nahomi; Tomoko Oya-Ito; Ram H Nagaraj
Journal:  Biochim Biophys Acta       Date:  2012-09-08

Review 2.  Lens aging: effects of crystallins.

Authors:  K Krishna Sharma; Puttur Santhoshkumar
Journal:  Biochim Biophys Acta       Date:  2009-05-20

3.  Substrate Protein Interactions and Methylglyoxal Modifications Reduce the Aggregation Propensity of Human Alpha-A-Crystallin G98R Mutant.

Authors:  Puttur Santhoshkumar; Krishna K Sharma
Journal:  Front Mol Biosci       Date:  2022-04-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.